← Browse by Condition
Medical Condition

substance related disorders

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for substance related disorders sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — substance related disorders Clinical Trials

How many clinical trials are currently recruiting for substance related disorders?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for substance related disorders, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for substance related disorders?
substance related disorders research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a substance related disorders clinical trial?
Eligibility criteria for substance related disorders trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
University of New Mexico 1 trial
Chestnut Health Systems 1 trial
University of Utah 1 trial
University of Maryland, College Park 1 trial

Recruiting Clinical Trials

NCT05489068
Recruiting
Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
Enrollment
150 pts
Location
United States
Sponsor
University of New Mexico
View Trial →
NCT06852170
Recruiting
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
Enrollment
341 pts
Location
United States
Sponsor
Chestnut Health Systems
View Trial →
NCT06387290 Phase 3
Recruiting
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
Enrollment
300 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT05973838
Recruiting
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
Enrollment
160 pts
Location
United States
Sponsor
University of Maryland, Colleg...
View Trial →

Related Conditions

treatment adherence (2) substance abuse (1) decision making shared (1) implementation science (1) decision making (1) organizations (1) policy (1) chronic pain (1) prescription opioid misuse (1) pain (1) narcotic related disorders (1) chemically induced disorders (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology